Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNature Group Regulatory News (NGR)

  • There is currently no data for NGR

Annual Report and Accounts

20 Jun 2008 07:00

RNS Number : 1455X
Nature Technology Solutions Limited
20 June 2008
 



Nature Technology Solutions Limited 

(the "Company")

Report and Accounts and Notice of EGM

The Company announces that is has despatched to shareholders its report and accounts for the year ended 31 December 2007. The report and accounts can be viewed on the Company's website at www.investnature.co.uk.

The directors of the Company have been reviewing the future structure of the Company including its joint venture operations, and have commenced discussions as to how these operations might more beneficially be integrated into the Company. A number of new opportunities have been identified which the directors believe could be better exploited following the possible closer integration of certain of the Company's  activities. The directors will keep shareholders advised as to the conclusion of any discussions which lead to the onwards growth of the Company

The Company has convened an EGM for 16 July at which resolutions will be proposed to effect a 20 for 1 consolidation of the Company's issued and unissued ordinary shares and to increase the authorised share capital.

At present the issued share capital of the Company comprises 496,393,384 ordinary shares of 0.001p each ("Existing Shares"). It is proposed to consolidate every 20 Existing Shares into one new ordinary share of 0.2p ("New Ordinary Shares"). Upon the consolidation, there will be 24,819,669 New Ordinary Shares in issue.

The New Ordinary Shares will replace the Existing Shares each under the Company's Articles of Association and will carry equivalent rights.

As an example, a Shareholder holding 5,000 Existing Shares will, following the consolidation, hold 250 New Ordinary Shares. The proportionate interests of Shareholders will not be affected by the proposed consolidation save for the extent of fractional entitlements. Fractional entitlements will not be allocated but instead aggregated and sold in the market for the benefit of the Company. New share certificates will be posted to Shareholders in due course.

For further information, please contact:

Nature Technology Solutions Limited

Richard Eldridge, CEO  Tel: 01841 533 611

Nigel Sandy, Director Tel: 01373 473995

Seymour Pierce Limited

Jonathan Wright, Director Tel: 020 7107 8000 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACSEAKKNFSKPEFE
Date   Source Headline
23rd Jun 20084:07 pmRNSDirector/PDMR Shareholding
20th Jun 20087:00 amRNSAnnual Report and Accounts
10th Jun 200811:24 amRNSDirector/PDMR Shareholding
9th Jun 20087:00 amRNSDirector/PDMR Shareholding
6th Jun 200812:06 pmRNSDirector/PDMR Shareholding
4th Jun 20081:30 pmRNSDirector/PDMR Shareholding
3rd Jun 200811:09 amRNSDirector/PDMR Shareholding an
2nd Jun 20087:00 amRNSFinal Results
20th Mar 20084:25 pmRNSUpdate on disposal & training
5th Feb 20087:00 amRNSUpdate on JV sale & trading
29th Nov 20077:01 amRNSProposed sale of jv
21st Sep 20077:01 amRNSInterim Results
7th Sep 200710:14 amRNSAIM Rule 26
1st Jun 200711:50 amRNSFinal Results
22nd May 200710:11 amRNSAdmission to trading on PLUS
8th Feb 200712:22 pmRNSFurther re Board Appointment
5th Feb 20077:01 amRNSIssue of Equity
29th Sep 20067:01 amRNSInterim Results
28th Jul 20063:23 pmRNSDirector/PDMR Shareholding
26th Jul 200612:26 pmRNSDirector/PDMR Shareholding
24th Jul 20062:20 pmRNSDirector/PDMR Shareholding
18th Apr 20069:46 amRNSDirector/PDMR Shareholding
18th Apr 20069:02 amRNSIssue of Equity
7th Apr 20065:32 pmRNSDirector/PDMR Shareholding
29th Mar 20063:26 pmRNSFinal Results
28th Sep 20057:01 amRNSInterim Results
15th Jul 20054:08 pmRNSIssue of Equity
9th May 200512:01 pmRNSFinal Results
12th Jan 20052:29 pmRNSDirector Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.